论文部分内容阅读
Glioblastoma-multiforme(GBM),the most aggressive glial tumor,has a worldwide age-adjusted incidence ranging from 0.59-3.69/100000 persons.Despite current multimodal-treatment approach,median-survival time and progression-free survival(PFS)remains short.Gl